Physician profile
David J Hirsch
NPI 1588657423
$816.46
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $63.46 · 2021: $124 · 2022: $205 · 2023: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $118.34 | 2019-2023 | Myrbetriq, Veozah |
| Therapeuticsmd, INC. | $111.13 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.42 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $57.60 | 2021-2023 | |
| Abbvie INC. | $56.67 | 2021-2023 | |
| Allergan, INC. | $56.22 | 2019-2020 | |
| Exact Sciences Corporation | $46.19 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $42.52 | 2022-2023 | Slynd |
| Vertical Pharmaceuticals, LLC | $42.41 | 2019 | |
| Amag Pharmaceuticals, INC. | $34.99 | 2019-2020 | |
| Celularity INC. | $28.75 | 2019-2020 | |
| Avion Pharmaceuticals | $28.45 | 2022-2023 | Balcoltra |
| Pfizer INC. | $27.55 | 2020-2022 | |
| Alydia Health | $24.12 | 2021 | |
| Collegium Pharmaceutical, INC. | $20.35 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.05 | 2021 | |
| Scynexis, INC. | $14.91 | 2022 | |
| Evofem Biosciences, INC. | $13.93 | 2022 | |
| Lupin INC. | $12.86 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.